Summit Therapeutics

Related records

Trials (37)

• A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)
• A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
• A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
• A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)
• A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
• A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
• A Study of Ivonescimab in People With Endometrial and Cervical Cancers
• A Study of Ivonescimab in People With Leiomyosarcoma
• A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
• A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)
• A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
• A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
• Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
• Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy
• Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
• Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
• Ivonescimab for the Treatment of Thymic Cancer
• Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA